SCHEMBL25021700

SCHEMBL25021700

C/C=C/C1CCC[C@H]1COc1nc2c(c(N(CCC)CC(C)CC#N)n1)CC[C@H](/C=C/C(=C/CC)c1ccccc1C)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25020775 0.77 — —
SCHEMBL21895579 0.73 — —
SCHEMBL22086724 0.69 — —
SCHEMBL21846434 0.68 KRAS (0.32) —
SCHEMBL22087290 0.68 KRAS (0.36) —
SCHEMBL21912130 0.68 KRAS (0.36) —
SCHEMBL21912768 0.66 — —
SCHEMBL25019995 0.66 — —
SCHEMBL21896256 0.65 — —
SCHEMBL22087714 0.63 KRAS (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-02-15 — — EP disclosed
Send feedback